Found 19 matching trials
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer PHASE2 Study design: Prospective, single-arm, single-center phase II clinical stud...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors PHASE1 To evaluate the safety and tolerability of IBI3005 combination therapy in p...
Show More Location
SunYat-sen University Cancer Center
Learn More & Join Trial
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma PHASE2 This study is a randomized, open-label, positive-controlled, multicenter ph...
Show More Location
West China Hospital of Sichuan University
Learn More & Join Trial
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs PHASE2 To study the safety and clinical effect of injection of drug-eluting micros...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
IBI188 Combination Therapy in Solid Tumors PHASE1 A Phase Ib study aim to evaluate the efficacy, safety, and tolerability of ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC) PHASE1 There're 2 parts in this interventional study:
1. The goal of phase Ib tri...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma PHASE3 THis study aims to evaluate the efficacy of SHR-8068 combined with Adebreli...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma PHASE1 This study is to evaluate the feasibility and safety of personalized tumor ...
Show More Location
the First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma PHASE2 The purpose of this study is to assess the efficacy and safety of QL1706 in...
Show More Location
Nanjing Tianyinshan Hospital
Learn More & Join Trial
A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) PHASE2 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Learn More & Join Trial